Expensive drugs to curb for NHI financial stabilization.

Published: 2002-01-03 06:59:00

Updated: 2002-01-03 06:59:00

In line with the NHI financial stabilization measures, the MOHW made an aggressive plan for strict controls over the expensive drug medication at medical institutes to keep off the NHI financial burdens in advance and an establishment of standards for prescription convergence to specific pharmaci...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK